1. Home
  2. GBIO vs BAER Comparison

GBIO vs BAER Comparison

Compare GBIO & BAER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • BAER
  • Stock Information
  • Founded
  • GBIO 2016
  • BAER 2014
  • Country
  • GBIO United States
  • BAER United States
  • Employees
  • GBIO N/A
  • BAER N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • BAER Blank Checks
  • Sector
  • GBIO Health Care
  • BAER Finance
  • Exchange
  • GBIO Nasdaq
  • BAER Nasdaq
  • Market Cap
  • GBIO 165.5M
  • BAER 167.5M
  • IPO Year
  • GBIO 2020
  • BAER N/A
  • Fundamental
  • Price
  • GBIO $1.10
  • BAER $2.08
  • Analyst Decision
  • GBIO Strong Buy
  • BAER Strong Buy
  • Analyst Count
  • GBIO 2
  • BAER 1
  • Target Price
  • GBIO $7.50
  • BAER $5.75
  • AVG Volume (30 Days)
  • GBIO 425.8K
  • BAER 84.1K
  • Earning Date
  • GBIO 11-06-2024
  • BAER 11-11-2024
  • Dividend Yield
  • GBIO N/A
  • BAER N/A
  • EPS Growth
  • GBIO N/A
  • BAER N/A
  • EPS
  • GBIO N/A
  • BAER N/A
  • Revenue
  • GBIO $18,582,000.00
  • BAER $84,136,000.00
  • Revenue This Year
  • GBIO $212.74
  • BAER $41.90
  • Revenue Next Year
  • GBIO N/A
  • BAER N/A
  • P/E Ratio
  • GBIO N/A
  • BAER N/A
  • Revenue Growth
  • GBIO 514.08
  • BAER 26.12
  • 52 Week Low
  • GBIO $0.75
  • BAER $1.71
  • 52 Week High
  • GBIO $4.65
  • BAER $7.82
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 34.72
  • BAER 29.23
  • Support Level
  • GBIO $1.03
  • BAER $2.03
  • Resistance Level
  • GBIO $1.12
  • BAER $2.36
  • Average True Range (ATR)
  • GBIO 0.13
  • BAER 0.17
  • MACD
  • GBIO 0.02
  • BAER -0.01
  • Stochastic Oscillator
  • GBIO 55.56
  • BAER 9.72

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About BAER Bridger Aerospace Group Holdings Inc.

Bridger Aerospace Group Holdings Inc operates as an aerial firefighting company. It provides aerial wildfire surveillance, relief and suppression, and aerial firefighting services using next-generation technology and environmentally friendly and sustainable firefighting methods. Bridger Aerospace provides aerial firefighting and wildfire management services to federal and state government agencies, including the United States Forest Service, across the nation. The company's portfolio is organized across two offerings: Fire Suppression, which Consists of deploying specialized Viking CL-415EAF ("Super Scooper") aircraft to drop large amounts of water quickly and directly on wildfires, and Aerial Surveillance, providing aerial surveillance via manned aircraft for fire suppression aircraft.

Share on Social Networks: